In a recent update, Piper Sandler's analyst Patrick Moley has maintained the "Overweight" rating for CME Group (CME, Financial), indicating sustained confidence in the company's market performance.
The analyst has raised the price target for CME Group (CME, Financial) from USD 283.00 to USD 296.00. This adjustment represents a 4.59% increase from the prior target, reflecting an optimistic outlook for CME's future growth prospects.
The changes, announced on July 15, 2025, underscore the analyst's positive sentiment towards CME Group's strategic initiatives and potential market advancements. The firm's adjusted price target aligns with continued investor interest and market dynamics expected to benefit CME Group (CME, Financial).
Wall Street Analysts Forecast
Based on the one-year price targets offered by 15 analysts, the average target price for CME Group Inc (CME, Financial) is $282.87 with a high estimate of $313.00 and a low estimate of $213.00. The average target implies an upside of 3.28% from the current price of $273.88. More detailed estimate data can be found on the CME Group Inc (CME) Forecast page.
Based on the consensus recommendation from 18 brokerage firms, CME Group Inc's (CME, Financial) average brokerage recommendation is currently 2.6, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for CME Group Inc (CME, Financial) in one year is $258.83, suggesting a downside of 5.5% from the current price of $273.88. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the CME Group Inc (CME) Summary page.
